maleimide has been researched along with 3-(4-fluorophenylethylamino)-1-methyl-4-(2-methyl-1h-indol-3-yl)-1h-pyrrole-2,5-dione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beller, M; Brennführer, A; Frech, MJ; Hübner, R; Jaster, R; Karapetyan, G; Ortinau, S; Pews-Davtyan, A; Rolfs, A; Schmöle, AC | 1 |
1 other study(ies) available for maleimide and 3-(4-fluorophenylethylamino)-1-methyl-4-(2-methyl-1h-indol-3-yl)-1h-pyrrole-2,5-dione
| Article | Year |
|---|---|
Novel indolylmaleimide acts as GSK-3beta inhibitor in human neural progenitor cells.
Topics: beta Catenin; Cell Differentiation; Cell Proliferation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Maleimides; Neurons; Protein Kinase Inhibitors; Signal Transduction; Stem Cells; Wnt Proteins | 2010 |